the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation
NCT02635802 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1500
Last updated 2015-12-21
Summary
Remifentanil is one kind of opiates with strong analgesic effect,which has the rapid onset and short lasting duration. Remifentanil usually is used to help reducing the pain of patients with mechanical ventilation in ICU. Maybe it can also be used to ease the pain in ICU small short time operation.The purpose of this study is to determine (1) whether remifentanil is effective in small short time operations in ICU or not, (2) the save range of remifentanil in small short time operations in ICU, (3) and the adverse reaction that happens in these operations.
Conditions
- Critical Illness
Interventions
- DRUG
-
Remifentanil
a loading dose 1.0-2.0μg/kg remifentanil,intravenous injection slowly,time \>1min,then 5μg/kg·h pumping if the operation can not be done in 5 minutes. Critical-Care Observation Tool(CPOT) and Richmond Agitation-Sedation Scale(RASS) are assessed before and after the loading.We should maintain the CPOT≤2 and RASS 0~2,if it is not up to the standard,increasing the pumping rate 0.5 μg/kg·h every 2-5min.
- DRUG
-
Lidocaine
lidocaine 100-400mg,local anesthesia.Critical-Care Observation Tool(CPOT) and Richmond Agitation-Sedation Scale(RASS) are assessed before and after local anesthesia.We should maintain the CPOT≤2 and RASS 0~2.
- DRUG
-
Remifentanil+Lidocaine
a loading dose 1.0-2.0μg/kg remifentanil,intravenous injection slowly,time \>1min,then 5μg/kg·h remifentanil pumping immediately if the operation can not be done in 5 minutes.then local anesthesia with lidocaine 100-400mg.Critical-Care Observation Tool(CPOT) and Richmond Agitation-Sedation Scale(RASS) are assessed before and after anesthesia.We should maintain the CPOT≤2 and RASS 0~2,if it is not up to the standard,increasing the pumping rate 0.5μg/kg·h every 2-5min.
- DRUG
-
Midazolam
midazolam is an adjuvant drug.we should maintain the CPOT≤2 and RASS 0~2,if lidocaine is already used up to 400mg or the pumping rate of remifentanil is already 7.5μg/kg·h,then we should use midazolam 3mg, intravenous injection slowly.
Sponsors & Collaborators
-
Yichang Humanwell Pharmaceutical Co., Ltd., China
collaborator INDUSTRY -
The First Affiliated Hospital of Zhengzhou University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-09-30
More Related Trials
-
Sevoflurane-Remifentanil Interaction: Multiple Response Surfaces, Validation of Calibration Stimuli, Validation of the Intraoperative Isobole Concept and Investigating Remifentanil Induced Opioid Tolerance
NCT00522587 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Remazolam Besylate Combined With Remifentanil Analgesic Sedation on the Prognosis of Patients With Sepsis
NCT06731088 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Efficacy and Safety of Remifentanil for Mechanically Ventilated Patients in Intensive Care Unit
NCT05641909 ·Status: UNKNOWN ·Phase: PHASE3
-
Myocardial Protection and Anesthetic Agents
NCT02405689 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery
NCT05624424 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment
NCT06414018 ·Status: COMPLETED ·Phase: NA
-
Ketamine Infusion as Sedative Analgesic in Severe ARDS
NCT04818827 ·Status: COMPLETED
-
The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients
NCT04947345 ·Status: UNKNOWN ·Phase: PHASE3
-
REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults
NCT07155265 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study
NCT07089173 ·Status: RECRUITING ·Phase: NA
-
EICU Analgesia and Sedation Cross-sectional Survey
NCT04674540 ·Status: COMPLETED
-
Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit
NCT05027217 ·Status: COMPLETED
-
Comparison of Analgesic Effect and Prognosis of Butorphanol and Fentanyl in Patients With Mechanical Ventilation
NCT04315935 ·Status: UNKNOWN ·Phase: PHASE4
-
Three Anaesthesic Method in Electroconvulsive Theraphy
NCT01759589 ·Status: COMPLETED ·Phase: PHASE4
-
The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics
NCT03588429 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Remimazolam vs Sevoflurane Anesthesia on Incidence of Emergence Agitation and Complications in Children Undergoing Ophthalmic Surgery
NCT05527314 ·Status: COMPLETED ·Phase: NA
-
Remifentanil Requirement for Acceptable Intubating Condition
NCT02655380 ·Status: COMPLETED ·Phase: PHASE4
-
Remifentanil for Smooth Emergence in Elderly Patients
NCT02334046 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects
NCT00158873 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Remifentanil Compared to Lidocaine on the Incidence of Coughing During Emergence of Anesthesia
NCT01026129 ·Status: COMPLETED ·Phase: NA
-
Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol
NCT00586118 ·Status: COMPLETED
-
Ketamine Versus Propofol as ICU Sedation
NCT06243822 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Sedation Practice in Critically Ill Adult Patients Using a Co-designed Sedation Protocol
NCT07032987 ·Status: RECRUITING
-
Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval
NCT03458143 ·Status: UNKNOWN
-
Ketamine-fentanyl VS Fentanyl for Analgosedation in SICU
NCT03879564 ·Status: COMPLETED ·Phase: PHASE4